- Home
- GLBS vs MREO Comparison
GLBS vs MREO Comparison
Compare GLBS & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GLBS | MREO |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | Greece | United Kingdom |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.8M | 52.5M |
| IPO Year | 2010 | 2017 |
Fundamental Metrics
Financial Performance| Metric | GLBS | MREO |
|---|---|---|
| Price | $2.15 | $0.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $3.00 | $1.50 |
| AVG Volume (30 Days) | 59.2K | ★ 4.0M |
| Earning Date | 06-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $500,000.00 |
| Revenue This Year | $13.06 | $5,184.20 |
| Revenue Next Year | $20.20 | $55.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $0.20 |
| 52 Week High | $2.44 | $2.94 |
Technical Indicators
Market Signals| Indicator | GLBS | MREO |
|---|---|---|
| Relative Strength Index (RSI) | 58.00 | 57.66 |
| Support Level | $1.83 | $0.33 |
| Resistance Level | $2.18 | $0.36 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 75.00 | 74.37 |
Price Performance
Historical ComparisonAbout GLBS Globus Maritime Limited
Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).